Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
43
RPID Quote, Financials, Valuation and Earnings
Last price:
$4.06
Seasonality move
:
36.11%
Day range:
$3.95 - $4.24
52-week range:
$0.87 - $4.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.78x
P/B ratio:
3.98x
Volume:
90.2K
Avg. volume:
108.3K
1-year change:
286.41%
Market cap:
$176.4M
Revenue:
$28.1M
EPS (TTM):
-$1.00
Analysts' Opinion
-
Consensus RatingRapid Micro Biosystems, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $8.00, Rapid Micro Biosystems, Inc. has an estimated upside of 101.01% from its current price of $3.98.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.00 representing 100% downside risk from its current price of $3.98.
Fair Value
-
According to the consensus of 4 analysts, Rapid Micro Biosystems, Inc. has 101.01% upside to fair value with a price target of $8.00 per share.
RPID vs. S&P 500
-
Over the past 5 trading days, Rapid Micro Biosystems, Inc. has underperformed the S&P 500 by -5.31% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Rapid Micro Biosystems, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Rapid Micro Biosystems, Inc. has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Rapid Micro Biosystems, Inc. reported revenues of $7.8M.
Earnings Growth
-
Rapid Micro Biosystems, Inc. has grown year-over-year earnings for 9 quarters straight. In the most recent quarter Rapid Micro Biosystems, Inc. reported earnings per share of -$0.26.
Enterprise value:
159.3M
EV / Invested capital:
2.33x
Price / LTM sales:
5.78x
EV / EBIT:
--
EV / Revenue:
5.22x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.04x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.4M
Return On Assets:
-49.27%
Net Income Margin (TTM):
-145.11%
Return On Equity:
-68.33%
Return On Invested Capital:
-59.49%
Operating Margin:
-145.09%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $20.6M | $26.2M | $30.5M | $7.6M | $7.8M | |
| Gross Profit | -$7.9M | -$1.3M | $2.4M | $622K | $696K | |
| Operating Income | -$61.6M | -$51.9M | -$45.4M | -$12M | -$11.4M | |
| EBITDA | -$57.3M | -$48.3M | -$42.1M | -$11.2M | -$10.6M | |
| Diluted EPS | -$1.35 | -$1.11 | -$1.00 | -$0.26 | -$0.26 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $244.2M | $144.6M | $115M | $87.9M | $70M | |
| Total Assets | $254.4M | $201.9M | $150.2M | $105.8M | $84.4M | |
| Current Liabilities | $17.7M | $15.2M | $15.6M | $15.9M | $16.5M | |
| Total Liabilities | $19.7M | $22.9M | $22.4M | $21.5M | $40.1M | |
| Total Equity | $234.7M | $179M | $127.8M | $84.4M | $44.3M | |
| Total Debt | -- | $7.5M | $7.3M | $6.5M | $22.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$47.2M | -$43.7M | -$38.6M | -$8.6M | -$9.9M | |
| Cash From Investing | $44.9M | $41.8M | $15.3M | -$6.5M | -$9.6M | |
| Cash From Financing | $248K | $197K | $20.2M | $61K | $20.1M | |
| Free Cash Flow | -$49.5M | -$45.4M | -$39.5M | -$8.8M | -$10M | |
RPID
Sector
Market Cap
$176.4M
$28.5M
Price % of 52-Week High
88.44%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-2.78%
-1.33%
1-Year Price Total Return
286.41%
-20.32%
Beta (5-Year)
--
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$4.09
200-day SMA
Buy
Level
$3.09
Bollinger Bands (100)
Buy
Level
2.74 - 3.86
Chaikin Money Flow
Buy
Level
4M
20-day SMA
Sell
Level
$4.04
Relative Strength Index (RSI14)
Buy
Level
55.07
ADX Line
Buy
Level
28.18
Williams %R
Buy
Level
-80.3571
50-day SMA
Buy
Level
$3.51
MACD (12, 26)
Buy
Level
0.19
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-6.3773)
Sell
CA Score
(Annual)
Level (-0.859)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.5585)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Rapid Micro Biosystems, Inc. is a life sciences technology company. It provides automated solutions to facilitate the efficient manufacturing and safe release of healthcare products such as biologics, vaccines, cell & gene therapies, and sterile injectable. The company was founded by Donald Straus on December 29, 2006 and is headquartered in Lexington, MA.
Stock Forecast FAQ
In the current month, RPID has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RPID average analyst price target in the past 3 months is $8.00.
-
Where Will Rapid Micro Biosystems, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Rapid Micro Biosystems, Inc. share price will rise to $8.00 per share over the next 12 months.
-
What Do Analysts Say About Rapid Micro Biosystems, Inc.?
Analysts are divided on their view about Rapid Micro Biosystems, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Rapid Micro Biosystems, Inc. is a Sell and believe this share price will drop from its current level to $8.00.
-
What Is Rapid Micro Biosystems, Inc.'s Price Target?
The price target for Rapid Micro Biosystems, Inc. over the next 1-year time period is forecast to be $8.00 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RPID A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Rapid Micro Biosystems, Inc. is a Buy. 4 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of RPID?
You can purchase shares of Rapid Micro Biosystems, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Rapid Micro Biosystems, Inc. shares.
-
What Is The Rapid Micro Biosystems, Inc. Share Price Today?
Rapid Micro Biosystems, Inc. was last trading at $4.06 per share. This represents the most recent stock quote for Rapid Micro Biosystems, Inc.. Yesterday, Rapid Micro Biosystems, Inc. closed at $3.98 per share.
-
How To Buy Rapid Micro Biosystems, Inc. Stock Online?
In order to purchase Rapid Micro Biosystems, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get RPID Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RPID
Sector
P/E ratio
--
23.75x
PEG ratio
--
-0.01x
P/B ratio
3.98x
1.83x
Price / LTM sales
5.78x
1.60x
Growth Metrics
RPID
Sector
Revenue growth
3.08%
4.85%
Earnings growth
1.31%
11.11%
Revenue (5-year growth)
11.18%
6.45%
Earnings forecast
-$0.25
-$0.20
Profitability
RPID
Sector
Profitability FY 2024
-$109K
$3.6M
Return on invested capital
-59.49%
-30.98%
Return on assets
-49.27%
-27.62%
Return on equity
-68.33%
-36.69%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Mar
6
Estimated Next Earnings Date
Feb
6
Balance Sheet
RPID
Sector
Total cash
$41.2M
$27.2M
Short term investments
$33.8M
$25.7M
Total assets
$98.2M
$79.7M
Long term debt
$22.9M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
